Oryzon Genomics SA
MAD:ORY
Income Statement
Earnings Waterfall
Oryzon Genomics SA
Income Statement
Oryzon Genomics SA
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Gross Profit |
(4)
N/A
|
(4)
-5%
|
(3)
+15%
|
(2)
+27%
|
(2)
+8%
|
(2)
+21%
|
(1)
+19%
|
(1)
+18%
|
(1)
+29%
|
(1)
-33%
|
(1)
-16%
|
(1)
+18%
|
(1)
-25%
|
(1)
+36%
|
(1)
-47%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
|
| Selling, General & Administrative |
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Operating Income |
(7)
N/A
|
(7)
-2%
|
(6)
+12%
|
(5)
+11%
|
(5)
+6%
|
(5)
+10%
|
(5)
-2%
|
(5)
+4%
|
(4)
+6%
|
(4)
-4%
|
(5)
-5%
|
(4)
+6%
|
(5)
-10%
|
(5)
-2%
|
(5)
0%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(1)
|
|
| Non-Reccuring Items |
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(7)
N/A
|
(7)
-2%
|
(6)
+11%
|
(7)
-4%
|
(7)
-1%
|
(6)
+4%
|
(7)
-4%
|
(6)
+9%
|
(6)
+7%
|
(6)
-2%
|
(6)
-3%
|
(6)
+5%
|
(6)
-8%
|
(6)
+8%
|
(5)
+5%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
1
|
3
|
|
| Income from Continuing Operations |
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
|
| Net Income (Common) |
(5)
N/A
|
(5)
-10%
|
(4)
+19%
|
(4)
-5%
|
(4)
+0%
|
(4)
+17%
|
(4)
-12%
|
(3)
+15%
|
(3)
+14%
|
(4)
-33%
|
(4)
-4%
|
(4)
+8%
|
(4)
-15%
|
(4)
0%
|
(3)
+37%
|
|
| EPS (Diluted) |
-0.09
N/A
|
-0.09
N/A
|
-0.08
+11%
|
-0.08
N/A
|
-0.07
+12%
|
-0.06
+14%
|
-0.07
-17%
|
-0.06
+14%
|
-0.04
+33%
|
-0.06
-50%
|
-0.06
N/A
|
-0.06
N/A
|
-0.06
N/A
|
-0.06
N/A
|
-0.04
+33%
|
|